Clinical Trials Logo
  1. Home
  2. Degenerative Osteoarthritis
  3. NCT02687399

Determine the Efficacy of TT-173. Reducing the the Total Blood Loss Associated With Total Knee Arthroplasty (HESTAT)

Degenerative Osteoarthritis Clinical Trial

Official title:
A Phase II/III, Randomized, Controlled, Single Blind Study to Evaluate the Haemostatic Efficacy and Safety of Topically Applied TT-173 in Patients Undergoing Knee Arthroplasty

Clinical Trial Summary

The purpose of this study is to determine the haemostatic efficacy of TT-173, reducing the total blood loss associated with the total knee arthroplasty.

Clinical Trial Description

As the TT-173 has been cleared for use as a topical hemostatic agent, the proposed study will further investigate the safety and efficacy of TT-173 in the knee arthroplasty. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02687399
Study type Interventional
Source Thrombotargets Europe S.L
Contact Santiago Rojas, Manager
Phone +34936642040
Email santiagorojasz@thrombotargets.com
Status Recruiting
Phase Phase 2/Phase 3
Start date January 2016
Completion date December 2018
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05302934 - Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty
Active, not recruiting NCT03203330 - A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee Phase 3
Not yet recruiting NCT05276011 - A Study to Determine the Safety and Efficacy of TG-C in Subjects With Symptomatic Early Hip Osteoarthritis Phase 2
Active, not recruiting NCT03685110 - CoreHip - Post Market Clinical Follow-Up Study
Recruiting NCT05742763 - Platelet-Rich Plasma and the Effects of NSAIDs on Pain and Functional Scores in Knee Osteoarthritis Phase 1/Phase 2
Completed NCT02802085 - VEGA Prospective Kiel
Completed NCT01335243 - Efficacy and Safety Study of Lumbar Interbody Fusion With MatriTMBONE Associated With Autologous Bone Marrow Phase 2
Completed NCT02756702 - All Polyethylene Tibia-VEGA Kiel
Not yet recruiting NCT02776943 - UCMSC Transplantation in the Treatment of Cartilage Damage Phase 1/Phase 2
Completed NCT01626677 - Follow-Up Study of CARTISTEM® Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect Phase 3
Completed NCT01413061 - Study of Subtalar Arthrodesis Using AlloStem® Versus Autologous Bone Graft N/A
Completed NCT06254976 - Serum Nesfatin-1 and Human Cartilage Glycoprotein-39 Levels in Knee Osteoarthritis N/A
Recruiting NCT05427019 - Continuous Distal Adductor Canal Block With Periarticular Local Anesthetic Infiltration Versus Continuous Distal Adductor Canal Block Alone for Analgesia After Total Knee Arthroplasty N/A
Completed NCT03817632 - Orthopilot Elite Post-Market Clinical Follow-Up
Recruiting NCT03849885 - Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty Phase 4
Completed NCT03442855 - Non-Interventional, Multicenter Bicontact® E PMCF Study
Active, not recruiting NCT03291470 - Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee Phase 3
Completed NCT05291130 - AESCULAP® Plasmafit® Cementless Acetabular System With Vitelene® Vitamin E Stabilized Highly Crosslinked Polyethylene
Active, not recruiting NCT04255966 - Plasmafit® Revision Structan® Hip Endoprosthesis Cup